Journal
BIOLOGICAL & PHARMACEUTICAL BULLETIN
Volume 35, Issue 7, Pages 1054-1063Publisher
PHARMACEUTICAL SOC JAPAN
DOI: 10.1248/bpb.b11-00024
Keywords
(1S,2S,3E,7E,11E)-3,7,11,15-cembratetraen-17,2-olide; cembrenolide diterpene; HT-29; apoptosis; reactive oxygen species
Categories
Funding
- National Research Foundation of Korea
- Korean Government [NRF-2009-351-2-E00072]
- Jeju National University Hospital Research fund
- National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea [1120340]
Ask authors/readers for more resources
We observed that (1S,2S,3E,7E,11E)-3,7,11,15-Cembratetraen-17,2-olide (LS-1), marine cembrenolide diterpene, inhibited growth and induced apoptosis in colon cancer cells via a reactive oxygen species (ROS) dependent mechanism. Treatment of HT-29 cells with LS-1 resulted in ROS generation, which was accompanied by disruption of mitochondrial membrane potential, cytosolic release of cytochrome c, sub-G1 peak accumulation, activation of Bid, caspase-3, -8, and -9, and cleavage of poly(ADP-ribose) polymerase (PARP) along with the suppressive expression of B cell lymphoma-2 (Bcl-2). All these effects were significantly blocked on pretreatment with the ROS inhibitor N-acetylcysteine (NAC), indicating the involvement of increased ROS in the proapoptotic activity of LS-1. Moreover, we showed that LS-1 induced the phosphorylation of c-Jun N-terminal kinase (JNK) and dephosphorylation of p38, extracellular signal-regulated kinase (ERK), Akt, Src and signal transducer and activator of transcription (STAT)3, which were effectively attenuated by NAC. In addition, the expressions of antioxidant catalase and glutathione peroxidase were abrogated by treatment using LS-1 with or without NAC. These findings reveal the novel anticancer efficacy of LS-1 mediated by the induction of apoptosis via ROS generation in human colon cancer cells.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available